CN108490083A - 苏黄止咳胶囊的质量检测方法 - Google Patents
苏黄止咳胶囊的质量检测方法 Download PDFInfo
- Publication number
- CN108490083A CN108490083A CN201810173187.3A CN201810173187A CN108490083A CN 108490083 A CN108490083 A CN 108490083A CN 201810173187 A CN201810173187 A CN 201810173187A CN 108490083 A CN108490083 A CN 108490083A
- Authority
- CN
- China
- Prior art keywords
- capsule
- suhuang
- zhike
- reference substance
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 62
- 238000000034 method Methods 0.000 title claims abstract description 40
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 claims abstract description 84
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 claims abstract description 77
- 229960002179 ephedrine Drugs 0.000 claims abstract description 39
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims abstract description 36
- BPYGTFFYYOWDBC-LOVSFRALSA-N arctiin Natural products COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc3ccc(O[C@@H]4O[C@H](C)[C@@H](O)[C@H](O)[C@H]4O)c(OC)c3)cc1OC BPYGTFFYYOWDBC-LOVSFRALSA-N 0.000 claims abstract description 36
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 claims abstract description 35
- 229960003908 pseudoephedrine Drugs 0.000 claims abstract description 34
- 238000003556 assay Methods 0.000 claims abstract description 21
- BALXUFOVQVENIU-GNAZCLTHSA-N Ephedrine hydrochloride Chemical compound Cl.CN[C@@H](C)[C@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-GNAZCLTHSA-N 0.000 claims abstract description 17
- 229960002534 ephedrine hydrochloride Drugs 0.000 claims abstract description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 168
- 239000000243 solution Substances 0.000 claims description 56
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 55
- 239000013558 reference substance Substances 0.000 claims description 48
- 239000012085 test solution Substances 0.000 claims description 33
- 235000019441 ethanol Nutrition 0.000 claims description 26
- 238000002360 preparation method Methods 0.000 claims description 26
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 24
- 238000001514 detection method Methods 0.000 claims description 20
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 18
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 17
- 241001465251 Ephedra sinica Species 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000000047 product Substances 0.000 claims description 13
- 239000003480 eluent Substances 0.000 claims description 10
- 239000000945 filler Substances 0.000 claims description 10
- 229960003447 pseudoephedrine hydrochloride Drugs 0.000 claims description 10
- BALXUFOVQVENIU-KXNXZCPBSA-N pseudoephedrine hydrochloride Chemical compound [H+].[Cl-].CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-KXNXZCPBSA-N 0.000 claims description 10
- 239000011347 resin Substances 0.000 claims description 10
- 229920005989 resin Polymers 0.000 claims description 10
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 239000000377 silicon dioxide Substances 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 7
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 6
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 claims description 5
- 238000002604 ultrasonography Methods 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 238000005259 measurement Methods 0.000 claims description 2
- 239000003292 glue Substances 0.000 claims 1
- 238000012372 quality testing Methods 0.000 abstract description 2
- 238000002474 experimental method Methods 0.000 description 41
- 238000012360 testing method Methods 0.000 description 32
- 206010011224 Cough Diseases 0.000 description 11
- 238000001914 filtration Methods 0.000 description 9
- 235000004347 Perilla Nutrition 0.000 description 8
- 241000229722 Perilla <angiosperm> Species 0.000 description 8
- 235000003130 Arctium lappa Nutrition 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 238000011835 investigation Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 238000011084 recovery Methods 0.000 description 7
- JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical compound CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 238000010828 elution Methods 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- RUMOYJJNUMEFDD-UHFFFAOYSA-N perillyl aldehyde Chemical compound CC(=C)C1CCC(C=O)=CC1 RUMOYJJNUMEFDD-UHFFFAOYSA-N 0.000 description 5
- 240000005528 Arctium lappa Species 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000208843 Arctium Species 0.000 description 3
- 235000008078 Arctium minus Nutrition 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 241000361919 Metaphire sieboldi Species 0.000 description 3
- 241000244269 Peucedanum Species 0.000 description 3
- 240000006079 Schisandra chinensis Species 0.000 description 3
- 235000008422 Schisandra chinensis Nutrition 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 241000931705 Cicada Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 238000005464 sample preparation method Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- RUMOYJJNUMEFDD-SNVBAGLBSA-N (R)-(+)-Perillaldehyde Natural products CC(=C)[C@H]1CCC(C=O)=CC1 RUMOYJJNUMEFDD-SNVBAGLBSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 201000004897 cough variant asthma Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- -1 ephedrine hydrochlorides Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
Landscapes
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810173187.3A CN108490083B (zh) | 2018-03-02 | 2018-03-02 | 苏黄止咳胶囊的质量检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810173187.3A CN108490083B (zh) | 2018-03-02 | 2018-03-02 | 苏黄止咳胶囊的质量检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108490083A true CN108490083A (zh) | 2018-09-04 |
CN108490083B CN108490083B (zh) | 2020-10-09 |
Family
ID=63341212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810173187.3A Active CN108490083B (zh) | 2018-03-02 | 2018-03-02 | 苏黄止咳胶囊的质量检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108490083B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110687219A (zh) * | 2019-08-23 | 2020-01-14 | 扬子江药业集团北京海燕药业有限公司 | 一种苏黄止咳胶囊指纹图谱的检测方法及其应用 |
CN114288340A (zh) * | 2022-01-20 | 2022-04-08 | 北京大学 | 一种治疗头皮屑的药物组合物及其应用 |
CN116270821A (zh) * | 2022-01-26 | 2023-06-23 | 北京东方运嘉科技发展有限公司 | 一种苏黄止咳颗粒及其制备方法和质量标准 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102645493A (zh) * | 2012-04-17 | 2012-08-22 | 西藏奇正藏药股份有限公司 | 五味甘露制剂的检测方法 |
CN104007222A (zh) * | 2014-06-03 | 2014-08-27 | 扬子江药业集团北京海燕药业有限公司 | 苏黄止咳胶囊的检测方法 |
CN104849369A (zh) * | 2015-05-13 | 2015-08-19 | 济南康众医药科技开发有限公司 | 一种麻附甘药物质量检测方法 |
-
2018
- 2018-03-02 CN CN201810173187.3A patent/CN108490083B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102645493A (zh) * | 2012-04-17 | 2012-08-22 | 西藏奇正藏药股份有限公司 | 五味甘露制剂的检测方法 |
CN104007222A (zh) * | 2014-06-03 | 2014-08-27 | 扬子江药业集团北京海燕药业有限公司 | 苏黄止咳胶囊的检测方法 |
CN104849369A (zh) * | 2015-05-13 | 2015-08-19 | 济南康众医药科技开发有限公司 | 一种麻附甘药物质量检测方法 |
Non-Patent Citations (3)
Title |
---|
C. IMAZ ET AL.: "Comparison of various reversed-phase columns for the simultaneous determination of ephedrines in urine by high-performance liquid chromatography", 《JOURNAL OF CHROMATOGRAPHY A》 * |
国家药典委员会: "《中华人民共和国药典 2015年版一部》", 30 June 2015, 中国医药科技出版社 * |
孙瑜 等: "大孔吸附树脂对牛蒡子中牛蒡苷的纯化工艺研究", 《中国实验方剂学杂志》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110687219A (zh) * | 2019-08-23 | 2020-01-14 | 扬子江药业集团北京海燕药业有限公司 | 一种苏黄止咳胶囊指纹图谱的检测方法及其应用 |
CN110687219B (zh) * | 2019-08-23 | 2022-05-24 | 扬子江药业集团北京海燕药业有限公司 | 一种苏黄止咳胶囊指纹图谱的检测方法及其应用 |
CN114288340A (zh) * | 2022-01-20 | 2022-04-08 | 北京大学 | 一种治疗头皮屑的药物组合物及其应用 |
CN116270821A (zh) * | 2022-01-26 | 2023-06-23 | 北京东方运嘉科技发展有限公司 | 一种苏黄止咳颗粒及其制备方法和质量标准 |
Also Published As
Publication number | Publication date |
---|---|
CN108490083B (zh) | 2020-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101766771A (zh) | 一种治疗妇科疾病药物的质量控制方法 | |
CN108169386B (zh) | 一种颈腰康胶囊的hplc特征图谱的构建方法 | |
CN102269751B (zh) | 六味能消制剂的检测方法 | |
CN106822203B (zh) | 一种独活颗粒及其制备方法和质量控制方法 | |
CN108490083A (zh) | 苏黄止咳胶囊的质量检测方法 | |
CN112903867A (zh) | 一种苓桂术甘汤物质基准的质量控制方法 | |
CN108459090B (zh) | 济川煎组合物的质量控制方法 | |
CN100437112C (zh) | 一种治疗中老年眼部疾病中药制剂的质量检测方法 | |
CN101721475B (zh) | 一种腰痛宁胶囊的检测方法 | |
CN113533614B (zh) | 小承气汤物质基准的建立方法 | |
CN107449846A (zh) | Hplc‑ms测定小儿安神补脑颗粒中有效成分的方法 | |
CN101926889A (zh) | 芍杞颗粒剂的检测方法 | |
CN101700262A (zh) | 穿心莲滴丸的质量控制方法 | |
CN102552515A (zh) | 一种养血当归糖浆的质量检测方法 | |
CN103344738A (zh) | 九味镇心颗粒的检测方法 | |
CN104849384B (zh) | 建立健肝乐制剂指纹图谱的方法及其应用 | |
CN104655748B (zh) | 一种灯盏花颗粒指纹图谱及其建立方法与应用 | |
CN104873686A (zh) | 参茸补脑胶囊的质量检测方法 | |
CN102706984A (zh) | 采用高效液相测定清肺消炎丸中盐酸麻黄碱含量的方法 | |
CN100372563C (zh) | 治疗支气管炎的复方制剂及其制备方法、质量控制方法 | |
CN113759057B (zh) | 一种薤白水提取物及其制剂的特征图谱及其构建方法 | |
CN102078380A (zh) | 通便中药胶囊制剂及其制备方法和检测方法 | |
CN104111295A (zh) | 一种中药制剂的质量控制方法 | |
CN101028474B (zh) | 一种具有壮阳益肾功能中药制剂补肾康乐的质量检测方法 | |
CN108614066A (zh) | 一种治疗冠心病的中药药物组合物检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 100029 Beijing Chaoyang District Huixin East Street No. 2 Residence General Real Estate Building 801 Applicant after: BEIJING ORIENTAL FORTUNE TECHNOLOGY DEVELOPMENT Co.,Ltd. Address before: Room 2207, Block A, World Olympics International Center 101, Shaoyaojubeili, Chaoyang District, Beijing, 100029 Applicant before: BEIJING ORIENTAL FORTUNE TECHNOLOGY DEVELOPMENT Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 801, Zhuzong real estate building, A2 Huixin East Street, Chaoyang District, Beijing 100029 Patentee after: Beijing Dongfang Yunjia Pharmaceutical Co.,Ltd. Address before: 100029 Beijing Chaoyang District Huixin East Street No. 2 Residence General Real Estate Building 801 Patentee before: BEIJING ORIENTAL FORTUNE TECHNOLOGY DEVELOPMENT Co.,Ltd. |
|
CP03 | Change of name, title or address |